An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life

The clinical application of conventional peptide drugs often is limited by their short in vivo half-life and potential immunogenicity. Frequent injection presents challenges to the treatment of chronic diseases, such as HIV infection. We chemically modified a peptide HIV fusion inhibitor with 3-male...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Xie, Dong, Yao, Cheng, Wang, Li, Min, Wenjie, Xu, Jiahong, Xiao, Jiahai, Huang, Mingxian, Chen, Bo, Liu, Bin, Li, Xiaolin, Jiang, He
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2010
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798538/
https://ncbi.nlm.nih.gov/pubmed/19858258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00976-09
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller